These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. Mycophenolate mofetil in the treatment of chronic non-infectious, non-necrotizing scleritis. Kolomeyer AM; Ragam A; Shah K; Jachens AW; Tu Y; Chu DS Ocul Immunol Inflamm; 2012 Apr; 20(2):113-8. PubMed ID: 22409564 [TBL] [Abstract][Full Text] [Related]
32. Mycophenolate mofetil therapy in the management of inflammatory bowel disease--a retrospective case series and review. Smith MR; Cooper SC J Crohns Colitis; 2014 Aug; 8(8):890-7. PubMed ID: 24507162 [TBL] [Abstract][Full Text] [Related]
33. Mycophenolate mofetil therapy in uveitis: analysis of eight cases in a tertiary ophthalmic care centre in India. Rathore VM; Agrawal R; Chaudhary SP; Biswas J Int Ophthalmol; 2009 Apr; 29(2):117-22. PubMed ID: 18080093 [TBL] [Abstract][Full Text] [Related]
34. Mycophenolate mofetil as a steroid-sparing agent in sarcoid-associated renal disease. Zaidi AA; DeVita MV; Michelis MF; Rosenstock JL Clin Nephrol; 2015 Jan; 83(1):41-4. PubMed ID: 24075023 [TBL] [Abstract][Full Text] [Related]
35. Effect and safety of mycophenolate mofetil in chronic pulmonary sarcoidosis: a retrospective study. Brill AK; Ott SR; Geiser T Respiration; 2013; 86(5):376-83. PubMed ID: 23295253 [TBL] [Abstract][Full Text] [Related]
36. Effect of Corticosteroid-Sparing Treatment With Mycophenolate Mofetil vs Methotrexate on Inflammation in Patients With Uveitis: A Randomized Clinical Trial. Rathinam SR; Gonzales JA; Thundikandy R; Kanakath A; Murugan SB; Vedhanayaki R; Lim LL; Suhler EB; Al-Dhibi HA; Doan T; Keenan JD; Rao MM; Ebert CD; Nguyen HH; Kim E; Porco TC; Acharya NR; JAMA; 2019 Sep; 322(10):936-945. PubMed ID: 31503307 [TBL] [Abstract][Full Text] [Related]
37. A randomized clinical trial comparing methotrexate and mycophenolate mofetil for noninfectious uveitis. Rathinam SR; Babu M; Thundikandy R; Kanakath A; Nardone N; Esterberg E; Lee SM; Enanoria WT; Porco TC; Browne EN; Weinrib R; Acharya NR Ophthalmology; 2014 Oct; 121(10):1863-70. PubMed ID: 24917273 [TBL] [Abstract][Full Text] [Related]
38. Mycophenolate mofetil is safe, well tolerated, and preserves lung function in patients with connective tissue disease-related interstitial lung disease. Swigris JJ; Olson AL; Fischer A; Lynch DA; Cosgrove GP; Frankel SK; Meehan RT; Brown KK Chest; 2006 Jul; 130(1):30-6. PubMed ID: 16840379 [TBL] [Abstract][Full Text] [Related]
39. Efficacy of mycophenolate mofetil in sarcoidosis. Hamzeh N; Voelker A; Forssén A; Gottschall EB; Rose C; Mroz P; Maier LA Respir Med; 2014 Nov; 108(11):1663-9. PubMed ID: 25301291 [TBL] [Abstract][Full Text] [Related]
40. [Acute tubulointerstitial nephritis associated with uveitis (TINU). Treatment of the ocular inflammation with mycophenolate mofetil]. Sánchez Román J; Castillo Palma MJ; Ocaña Medina C; Rueda Rueda T Med Clin (Barc); 1998 Nov; 111(16):638. PubMed ID: 9881342 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]